CTC Clinical Trial Consultants AB — Clinical Trial Site

70 Registered trials

12 Currently recruiting

Organisation

CTC Clinical Trial Consultants AB

Location

Uppsala, Sweden

Identifier

ORG-100028585

Address

Vetenskapens Graend 11, 431 53, Sweden

Departments

#7510
#7511
#7512
Akademiska sjukhuset
Clinical Trial Consultants
Clinical Trial Consultants AB
Clinical Trial Consultants AB, Dag Hammarskjöldsväg 14, 752 37 Uppsala
Clinical trials
CTC
CTC AB
CTC Akademiska
CTC Clinical Trial Consultants
CTC Clinical Trial Consultants AB
CTC Clinical Trial Consultants AB, CTC Karolinska
CTC Ebbe Park
CTC EbbePark Linköping
CTC Ebbepark, Linköping
CTC GoC Gothenburg
CTC GoCo
CTC GoCO Molndal
CTC GoCo Möndal
CTC GoCo, Göteborg
CTC Karolinska
CTC Karolinska Stockholm
CTC MTC
CTC MTC, Uppsala
CTC Oscar
CTC Sjukhuskliniken, Uppsala
CTC Uppsala
Department Lung- och allergy diseases
Dermatology Department
Kardiologi
Lung- och allergimottagningen
Lungkliniken
MTC
N/A
NA
Uppsala University Hospital
VO Neuro / IMV

Clinical trials at this site (70)

Search interface

Ixekizumab Diabetes Intervention Trial (I-DIT) Ended

2023-508588-58-00 Diabetes type 1 4 2022-10-25
A phase 1, randomized, double-blind, single-center, placebo-controlled first-in-human trial to assess the safety, tolerability, pharmacokine… Halted

2023-510371-55-00 Complement-mediated diseases 1 2024-11-14
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine… Halted

2023-504215-32-00 Overweight and obesity 9 2023-09-28
A randomized, three-period, single-dose crossover trial in healthy female volunteers to demonstrate bioequivalence of tafoxiparin following … Ended

2025-521140-38-00 Labor priming 2 2026-02-11
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended

2025-523879-34-00 Nicotine use 2 2025-11-17
An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the ph… Ended

2024-518194-34-00 Helicobacter pylori infection, GERD 3 2025-11-11
A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of … Ended

2025-522287-32-00 Depression 3 2025-10-22
A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and prelimi… Ended

2024-517920-21-00 knee osteoarthritis 9 2025-08-19
A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration … Ended

2024-517605-91-00 advanced liver fibrosis 3 2025-05-26
A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid (… Ended

2025-520702-35-00 Idiopahtic pulmonary fibrosis 3 2025-05-14
A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended

2024-520122-11-00 Obesity 4 2025-05-07
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food… Ended

2024-515078-28-00 Diabetic Retinopathy 3 2025-04-16
A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS Ended

2024-515378-28-00 Immune system Diseases 1 2025-04-03
An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Ended

2024-514496-18-01 Hepatocellular carcinoma, renal cell carcinoma and diff 3 2025-01-30
An open-label, randomised, single-dose, three-way cross-over trial to assess the pharmacokinetics of NIC24-01 and NIC24-02 oromucosal pouche… Ended

2024-514676-40-00 Nicotine dependence 3 2024-12-12
A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec… Ended

2024-515065-34-00 Erectile dysfunction (ED) 4 2024-11-07
A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of all… Ended

2024-518757-42-00 Difficult-to-heal venous leg ulcers 9 2024-10-28
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With… Ended

2024-513143-82-00 Heart failure with reduced ejection fraction 3 2024-10-15
An open-label, crossover trial in otherwise healthy volunteers with allergic rhinitis to evaluate the relative bioavailability and hemodynam… Ended

2024-514037-38-00 Anaphylaxis 3 2024-10-01
A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volun… Ended

2024-515124-36-00 Apathy in neurodegenerative disorders 3 2024-09-24
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
A First-in-Human, randomised, double blind, placebo-controlled, single ascending dose trial to evaluate safety, tolerability, and pharmacoki… Ended

2023-507939-38-00 Urinary tract infections (UTIs)/complicated UTI (cUTI) 1 2024-08-28
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TO… Ended

2024-512893-86-00 Actinic keratosis 3 2024-08-06